Company Profile
Mestag Therapeutics Ltd
12466144•Private Limited With Share Capital
Get Full Access
17/02/2020
6 years
9
46
72110
low risk
Company Overview
Registration, classification & business activity
Mestag Therapeutics Ltd (12466144) is a private limited with share capital incorporated on 17/02/2020 (6 years old) and registered in saffron walden, CB101XL. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for cancer and inflammatory diseases. through our unique understanding of fibroblast biology, we are advancing a pipeline of first-in-class tailored antibody programs and targets for new treatments.backed by commit...
Financial Overview
£14.78M
£59.61M
£-44.83M
£6.98M
£8.95M
Key Metrics
46
Employees
9
Directors
47
Shareholders
Board of Directors
Charges
2
Registered
0
Outstanding
0
Part Satisfied
2
Satisfied
Innovate Grants
This company received a grant of £1534440.6 for Mestag: Unlocking Anti-Tumour Immune Responses In Solid Tumour Patients Using A First-In-Class Bispecific Antibody To Induce Tertiary Lymphoid Structures. The project started on 01/08/2024 and ended on 31/07/2025.
Import / Export
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating